Consultation meeting at EMA: Joint effort of the RADAR-CNS and RADAR-AD consortium members
On the 4th of February 2020, RADAR-CNS and RADAR-AD project members visited the European Medicines
RADAR-AD
First RADAR-AD clinical site visit in Thessaloniki, Greece
On the 11 and 12 February, Marijn Muurling and Casper de Boer from Amsterdam UMC
RADAR-AD members hold ethics interviews with patients and carers from Patient Advisory Board
“It is crucial for us to analyse at an early stage what emerging ethical and
RADAR-AD’s UK sites – KCL and University of Oxford, with successful applications to the NIHR portfolio
We are pleased to announce that both of RADAR-AD’s UK sites, King’s College London and
Neuronet convenes annual event on European research collaboration in Alzheimer’s disease and beyond
Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together
Neuronet Scientific Coordination Board meeting brings together project leaders in The Hague
On 23 October (The Hague, Netherlands), Neuronet (Efficiently Networking European Neurodegeneration Research) convened the second
RADAR-AD represented at European Commission’s Research and Innovation Days in Brussels
Researchers presented the work of the RADAR-AD project at the exhibition “Science is Wonderful!” on
Neuronet campaign launches on social media – Why we do what we do
Neuronet’s communication team and our community of communication representatives are pleased to announce that we will celebrate our projects.
Neuronet Scientific Coordination Board meeting brings together project leaders
Neuronet’s high-level, overarching Scientific Coordination Board is formed by 15 leaders of Innovative Medicines Initiative projects focussed on neurodegeneration.
New Research Consortium Aims to Measure Progression of Alzheimer’s Disease Through Use of Digital Technologies
A new international consortium of academic and industrial leaders in the field of Alzheimer’s Disease is pleased to announce the launch of “RADAR-AD”.